LLY

1,080.21

+1.73%↑

JNJ

223.5

+0.31%↑

ABBV

217.16

+0.73%↑

UNH

377.97

+0.23%↑

MRK

114.86

-0.95%↓

LLY

1,080.21

+1.73%↑

JNJ

223.5

+0.31%↑

ABBV

217.16

+0.73%↑

UNH

377.97

+0.23%↑

MRK

114.86

-0.95%↓

LLY

1,080.21

+1.73%↑

JNJ

223.5

+0.31%↑

ABBV

217.16

+0.73%↑

UNH

377.97

+0.23%↑

MRK

114.86

-0.95%↓

LLY

1,080.21

+1.73%↑

JNJ

223.5

+0.31%↑

ABBV

217.16

+0.73%↑

UNH

377.97

+0.23%↑

MRK

114.86

-0.95%↓

LLY

1,080.21

+1.73%↑

JNJ

223.5

+0.31%↑

ABBV

217.16

+0.73%↑

UNH

377.97

+0.23%↑

MRK

114.86

-0.95%↓

Home・Aktien・Lisata Therapeutics

L
Lisata Therapeutics

Geschlossen

3.43 -0.87

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

3.27

Max

3.51

Schlüsselkennzahlen
By Trading Economics
Einkommen	-1.5M -4.5M
Gewinnspanne	-2,954
Angestellte	21

Dividenden
By Dow Jones
Nächstes Ergebnis	6. Aug. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	3.3M 27M
Vorheriger Eröffnungskurs	4.3
Vorheriger Schlusskurs	3.43

Lisata Therapeutics Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

3. Juni 2026, 23:22 UTC

Ergebnisse

Wichtige Markttreiber

Broadcom Shares Slide Despite Jump in 2Q Revenue on AI Chip Demand -- Update

3. Juni 2026, 23:09 UTC

Heiße Aktien

Stocks to Watch: Broadcom, CrowdStrike, PVH, Petco

3. Juni 2026, 20:51 UTC

Ergebnisse

Costco Reports 15% Sales Growth in May

3. Juni 2026, 20:43 UTC

Ergebnisse

Broadcom 2Q Revenue Climbs on AI Chip Demand

3. Juni 2026, 23:48 UTC

Market Talk

Nikkei May Fall Amid Renewed Concerns About Iran Conflict -- Market Talk

3. Juni 2026, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

3. Juni 2026, 23:35 UTC

Market Talk

Oil Futures Fall on Possible Technical Correction -- Market Talk

3. Juni 2026, 23:15 UTC

Market Talk

Ergebnisse

Five Below, Broadcom and Crowdstrike Fall Despite Solid Results -- Market Talk

3. Juni 2026, 22:08 UTC

Heiße Aktien

After-Hours Stocks to Watch: CrowdStrike, Broadcom, Five Below -- WSJ

3. Juni 2026, 21:54 UTC

Market Talk

Correction to Oil Futures Rise on Concerns About U.S.-Iran Talks Article on June 1

3. Juni 2026, 21:18 UTC

Ergebnisse

Broadcom's Non-AI Semiconductor Revenue Rose 6% in 2Q, CEO Says

3. Juni 2026, 21:15 UTC

Ergebnisse

Broadcom CEO: Google Partnership Continues to Be 'Very Substantial'

3. Juni 2026, 21:13 UTC

Ergebnisse

Broadcom CEO Expects AI Semiconductor Revenue Growth to Continue in Fiscal 2028

3. Juni 2026, 21:13 UTC

Ergebnisse

Broadcom Continues to Expect AI Semiconductor Revenue of More Than $100B in 2027, CEO Says

3. Juni 2026, 21:12 UTC

Ergebnisse

Broadcom Expects AI Semiconductor Revenue of $56B This Year, CEO Says

3. Juni 2026, 21:09 UTC

Ergebnisse

Broadcom CEO: Networking Made Up Almost 40% of AI Revenue in 2Q

3. Juni 2026, 21:03 UTC

Ergebnisse

Broadcom Stock Falls After Earnings. Here's Why. -- Barrons.com

3. Juni 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

3. Juni 2026, 20:43 UTC

Ergebnisse

CrowdStrike Stock Falls Despite Earnings Beat -- Barrons.com

3. Juni 2026, 20:39 UTC

Akquisitionen, Fusionen, Übernahmen

Bill Ackman's Pershing Square Set To Make $600 Million on Universal Stake -- 4th Update

3. Juni 2026, 20:37 UTC

Akquisitionen, Fusionen, Übernahmen

Bill Ackman's Pershing Square Set To Make $600 Million on Universal Stake -- 3rd Update

3. Juni 2026, 20:35 UTC

Ergebnisse

Broadcom Stock Falls Despite Record Results -- Barrons.com

3. Juni 2026, 20:21 UTC

Akquisitionen, Fusionen, Übernahmen

Bill Ackman's Pershing Square Set To Make $600 Million on Universal Stake -- 2nd Update

3. Juni 2026, 20:17 UTC

Ergebnisse

Broadcom 2Q Semiconductor Solutions Revenue $15B >AVGO

3. Juni 2026, 20:17 UTC

Ergebnisse

Broadcom Sees 3Q Semiconductor Revenue From AI $16B >AVGO

3. Juni 2026, 20:15 UTC

Akquisitionen, Fusionen, Übernahmen

Bill Ackman's Pershing Square Set To Make $600 Million on Universal Stake -- Update

3. Juni 2026, 20:15 UTC

Ergebnisse

Broadcom 2Q Adj EPS $2.44 >AVGO

3. Juni 2026, 20:15 UTC

Ergebnisse

Broadcom 2Q EPS $1.91 >AVGO

3. Juni 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

3. Juni 2026, 20:15 UTC

Ergebnisse

Broadcom 2Q Rev $22.19B >AVGO

Peer-Vergleich

Kursveränderung

Lisata Therapeutics Prognose

Rating-Konsens

By TipRanks

Neutral

1 ratings

Buy

Halten

Sell

Basierend auf 1 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lisata Therapeutics – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Gewinn vor Steuern

Verkäufe

Betriebsergebnis

Über Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.